Interactions between neurons and astrocytes are crucial in both synapse or spine development and synaptic transmission 1 . Astrocytes release substances such as the matrix-associated protein thrombospondin to regulate synaptogenesis, and several other factors, including the neurotransmitter D-serine, to regulate synaptic transmission 2, 3 . At excitatory synapses, astrocytes can sense synaptic activity by detecting glutamate released from presynaptic terminals and respond to this stimulus with the release of gliotransmitters that, in turn, modulate the activity of the neurons 2,3 . Glutamate released into the synaptic cleft is cleared by a set of high-affinity transporters found on neurons and astrocytes. The glial transporters are responsible for clearing most glutamate in the hippocampus 4 . Rapid removal from the extracellular milieu restrains spill-over of glutamate to nearby synapses and protects cells from glutamate excitotoxicity 4, 5 . Glutamate uptake by astrocytes is dynamic and increases during neuronal activity, including long-term potentiation [5] [6] [7] . However, the molecular mechanisms that regulate glutamate transport in astrocytes are poorly understood, and it is unclear to what extent astrocytes contribute to long-term synaptic plasticity.
Interactions between neurons and astrocytes are crucial in both synapse or spine development and synaptic transmission 1 . Astrocytes release substances such as the matrix-associated protein thrombospondin to regulate synaptogenesis, and several other factors, including the neurotransmitter D-serine, to regulate synaptic transmission 2, 3 . At excitatory synapses, astrocytes can sense synaptic activity by detecting glutamate released from presynaptic terminals and respond to this stimulus with the release of gliotransmitters that, in turn, modulate the activity of the neurons 2, 3 . Glutamate released into the synaptic cleft is cleared by a set of high-affinity transporters found on neurons and astrocytes. The glial transporters are responsible for clearing most glutamate in the hippocampus 4 . Rapid removal from the extracellular milieu restrains spill-over of glutamate to nearby synapses and protects cells from glutamate excitotoxicity 4, 5 . Glutamate uptake by astrocytes is dynamic and increases during neuronal activity, including long-term potentiation [5] [6] [7] . However, the molecular mechanisms that regulate glutamate transport in astrocytes are poorly understood, and it is unclear to what extent astrocytes contribute to long-term synaptic plasticity.
In mouse hippocampus and cerebral cortex, signaling by Eph receptor tyrosine kinases and their cell surface-associated ephrin ligands has been implicated in synapse and spine formation 8, 9 . B-type Eph receptors-which interact with transmembrane ephrin-Bs-regulate synapse/spine development, at least in part by trans-synaptic interaction with ephrin-Bs expressed in axon terminals 10 . In contrast, the A-type Eph receptor, EphA4, which has the potential to interact with both A-type and B-type ephrins, has been suggested to interact with ephrin-A3 expressed on astrocytic processes. Activation of EphA4 forward signaling reduces spine length, whereas inhibition of EphA4 signaling increases spine length 11 . Hence, astrocytes use the Eph-ephrin system to shape spine morphology and possibly synaptic function.
Eph-ephrin signaling also promotes certain forms of hippocampal synaptic plasticity independently of morphological changes 9 . At the CA3-CA1 synapse (between cornu ammonis area 3 and area 1 neurons), both EphB2 and EphA4 are required for LTP; however, unlike the mechanism that promotes spine remodeling, both Eph receptors act in a kinase-independent fashion [12] [13] [14] . EphB2 may either act postsynaptically, by interacting in cis with NMDA receptors 15 , or presynaptically, interacting in trans with postsynaptic ephrin-Bs 9, 16 . Unlike EphB2, EphA4 does not seem to interact with NMDA receptors 15 , and the mechanism by which it promotes LTP is unknown.
Here we show that only postsynaptic dendritic, but not axonal, EphA4 is required for certain forms of LTP. Loss of ephrin-A3 affects the same forms of LTP and raises glutamate transporter currents in astrocytes. Loss of neuronal EphA4 increases, whereas transgenic overexpression of ephrin-A3 in astrocytes decreases, glial glutamate transporter abundance. The LTP deficiency observed in both Epha4 and Efna3 mutants is rescued by blocking glial glutamate transporters. These results suggest that interactions between dendritic EphA4 and ephrin-A3 control glial glutamate transport, which regulate synaptic glutamate concentration and postsynaptic depolarization and ultimately modulate the expression of LTP at excitatory synapses. 
RESULTS

EphA4 is required for LTP in postsynaptic CA1 cells
To remove EphA4 from subregions of the hippocampus, we used a conditional allele of EphA4 (Epha4 loxP , hereafter referred to as Epha4 lx ; K.K., unpublished results). PGK-cre;Epha4 lx/lx mice, in which EphA4 is ubiquitously deleted, showed phenotypes previously described in Epha4 null mutants (Supplementary Fig. 1 ) 17 . Although EphA4 expression in control Epha4 lx/lx mice is reduced to 15-20% of that in Epha4 +/+ mice ( Supplementary Fig. 1a ), this reduction did not cause phenotypic alterations (Supplementary Fig. 1 ). We also did not find alterations in CA3-CA1 LTP in control Epha4 lx/-mice, which only had one intact EphA4 allele, compared to Epha4 lx/+ mice ( Supplementary  Fig. 1j,k) . To generate CA1 pyramidal cell-specific Epha4 knockout mice, we used the R4Ag11CamK2a-cre mouse line (hereafter referred to as CA1-cre) 18 which shows full activity in CA1 at postnatal day (P) 31 ( Fig. 1a-c) . To generate CA3 pyramidal cell-specific EphA4 knockout mice, we used a new Grik4-cre knock-in mouse line (hereafter referred to as CA3-cre) that expresses Cre from the endogenous Grik4 locus (Supplementary Fig. 2 ). The CA3-cre line recombined in nearly all cells of CA3 and in a smaller fraction of dentate gyrus cells, starting from the first postnatal week (Fig. 1d-f) . The recombination efficiencies in the CA1-cre and CA3-cre lines, quantified by in situ hybridizations (Fig. 1g-i) , were approximately 80% for both lines (CA1/CA3 ratio in CA1-cre;Epha4 lx/-, 20% ± 12%, compared to 91% ± 4% in Epha4 lx/-; CA3/CA1 ratio in CA3-cre;Epha4 lx/-, 24% ± 4%, compared to 116% ± 7% in Epha4 lx/-; n = 3-5 mice; t-test, P < 0.0001). The recombination efficiency of the CA3-cre in the dentate gyrus was approximately 36% (data not shown).
CA1-cre;Epha4 lx/-and CA3-cre;Epha4 lx/-mice showed no gross developmental abnormalities. Before analyzing synaptic plasticity, we analyzed potential morphological alterations and basic synaptic parameters. Biolistic labeling with DiI in hippocampal slices Fig. 3 ). We tested AMPA and NMDA receptor functions, as well as CaMKIIα protein abundance, in Epha4 null mice and found them to be unaffected ( Supplementary  Fig. 4k,l) . To investigate a requirement for either postsynaptic (CA1) or presynaptic (CA3) EphA4 in LTP, we used theta-burst stimulation (TBS). After recording a stable baseline, three TBSs were given to fibers of the CA3 presynaptic neurons and LTP was recorded from CA1 neurons for up to 60 min after stimulation. Comparison of CA1-cre;Epha4 lx/-mice with littermate Epha4 lx/-controls revealed a marked reduction in LTP (Fig. 1j) comparable to the situation when EphA4 was removed postnatally from all pyramidal neurons of the forebrain (Camk2a-cre;Epha4 lx/-mice; Supplementary Fig. 3g,h ). In contrast, TBS-induced LTP was not altered in CA3-cre;Epha4 lx/-mice (Fig. 1k ). These results demonstrate that EphA4 functions postsynaptically to regulate LTP at the CA3-CA1 synapse.
Ephrin-A3 is required for TBS-induced LTP
Dendritic EphA4 has been shown to respond to ephrin-A3 expressed in astrocytes 11, 19 , and immunoelectron microscopic studies have suggested that EphA4 is expressed mainly perisynaptically 20 . We therefore asked whether ephrin-A3 function was critical for LTP. GLAST and GLT1 levels were 50% and 25% higher, respectively, in Epha4 -/-mice (GLAST **P = 0.009, n = 10 mice per group; GLT1 *P = 0.03, n = 15 mice; GFAP P = 0.2, n = 10 mice; EAAC1 P = 0.3, n = 3 mice; (i) GLAST abundance in CA1, but not CA3, was increased (GLAST in CA1, n = 7 mice, ***P = 0.0009; GLAST in CA3, n = 6 mice, P = 0.7; GLT1 in CA1, n = 13 mice, P = 0.07; GLT1 in CA3, n = 6 mice, P = 0.5; and GFAP, n = 6 mice, P = 0.9, t-test). Error bars, s.e.m.
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a r t I C l e S
We used an Efna3 null mutant mouse, which has alterations in spine morphology 19 but does not show significant defects in basal synaptic transmission parameters such as PPF, input-output ratios, and amplitude and frequency of miniature excitatory postsynaptic currents (mEPSCs), suggesting that the observed spine alterations are not critical for basic synaptic functions (Fig. 2a,b and Supplementary  Fig. 4 ). As with Epha4 mutants, LTP induced by a TBS protocol was strongly reduced in Efna3 -/-slices (Fig. 2c) . Notably, this LTP defect in Efna3 -/-slices was specific for TBS and was not observed after tetanic stimulation (Fig. 2d) . Therefore, the requirement of ephrin-A3 for LTP is dependent on a stimulus protocol that is physiologically closer to what happens in the hippocampus during learning and memory 21 , which suggests a direct, possibly signaling function of ephrin-A3 in LTP. The requirement for TBS-but not tetanus-induced LTP was also observed in EphA4 mutant mice (Fig. 2e,f and Supplementary Fig. 3h ). These findings suggest that EphA4 interacts with ephrin-A3 to regulate TBS-induced LTP at the CA3-CA1 synapse.
Glial glutamate transporter regulation by EphA4/ephrin-A3
Next, we reasoned that the EphA4 ectodomain may activate ephrin-A3 reverse signaling in astrocytes, thereby modulating astrocytic functions that impact on LTP. As glial glutamate transporters are known to regulate synaptic transmission by clearing glutamate from the synaptic cleft 5, 22 , we investigated the expression of the glial glutamate/aspartate transporter (GLAST or EAAT1) and glutamate transporter subtype-1 (GLT1/EAAT2) in our mutant mice. A marked upregulation of GLAST protein abundance and a modest increase in GLT-1 were observed in Epha4 -/-brains compared to littermate controls (Fig. 3a-c) . Amounts of glial fibrillary acidic protein (GFAP) and the neuronal excitatory amino acid carrier-1 (EAAC-1/EAAT3) were not altered (Fig. 3a-c) . Notably, the upregulation of GLAST and GLT-1 was rescued in Epha4 EGFP/EGFP mice, in which the cytoplasmic domain is replaced by GFP 12 , suggesting that the EphA4 ectodomain was sufficient to maintain normal GLAST and GLT-1 levels ( Fig. 3d-f) . GLAST upregulation was also seen in dissected CA1 regions, but not CA3 regions, of CA1-cre;Epha4 lx/-mice compared to that in littermate controls ( Fig. 3g-i) . Similar changes in GLAST and GLT-1 were observed in Efna3 -/-mice 19 . These results suggest that the EphA4 ectodomain, presumably by interacting with ephrin-A3, restricts the expression of glial glutamate transporters. These changes were not secondarily caused by an increase in astrocyte numbers in Epha4 -/-mice, and the regulation appeared to happen at the post-transcriptional level, as the amounts of Slc1a3 and Slc1a2 mRNAs (encoding GLAST and GLT-1, respectively) in Epha4 -/-and Efna3 -/-mice were similar to those in control mice (Supplementary Fig. 5 ).
The upregulation of glial glutamate transporters may result in increased glutamate transporter currents in mutant astrocytes. We performed whole-cell patch-clamp recordings from astrocytes in the stratum radiatum of Efna3 -/-hippocampal slices. Transporter currents were evoked by endogenous release of glutamate from presynaptic terminals upon Schaffer collateral stimulation. The mean peak amplitude of transporter currents normalized to the respective fiber volley in response to single-pulse stimulation was significantly higher in Efna3 -/-than in littermate controls (Fig. 4 and Supplementary  Fig. 6 ). Similar results were obtained with a TBS protocol (Fig. 4b,c and Supplementary Fig. 6 ), which had produced a much reduced LTP in Efna3 −/− mice (Fig. 2) . These results indicate that glutamate uptake by astrocytes in response to a single burst or a TBS protocol was significantly elevated in Efna3 −/− mice.
Glutamate concentration near synapses and effect on LTP
We next asked whether elevation of glutamate transporter abundance in astrocytes would decrease synaptic glutamate. To estimate synaptic glutamate concentrations, we performed whole-cell patch-clamp recordings from CA1 hippocampal neurons in acute slices in the presence of the low-affinity competitive AMPA receptor antagonist γ-D-glutamylglycine (γ-DGG). γ-DGG binds non-NMDA receptors with low affinity and with rapid dissociation kinetics comparable to the dissociation kinetics of synaptically released glutamate 23, 24 . Thus, the degree of inhibition by γ-DGG is sensitive to the concentration of glutamate. If less glutamate is present, the inhibition by γ-DGG is stronger. We found comparable amplitudes and frequencies of mEPSCs in slices derived from Epha4 -/-mice and Epha4 +/+ littermate a r t I C l e S controls ( Fig. 5a and Supplementary Fig. 4a-d) . γ-DGG reduced the amplitude of mEPSCs in Epha4 -/-slices more than in Epha4 +/+ controls (Fig. 5b) , indicating that glutamate concentrations near synapses in Epha4 -/-slices are reduced. These results suggest that the clearance of glutamate is more efficient in the EphA4 mutants, possibly because of the upregulation of glial glutamate transporters.
To test whether the changes in glutamate concentration resulted in insufficient postsynaptic depolarization, we analyzed fEPSPs during high-frequency stimulation. fEPSP slopes at the end of the first train of each TBS were significantly reduced in CA1-cre;Epha4 lx/-and Efna3 -/-, but not CA3-cre;Epha4 lx/-mice, compared to those in their respective controls (Fig. 5c-e) . Next, we investigated the effects of blocking glutamate reuptake on LTP. We used (2S, 3S)-3-{3-[4-(trifluorome thyl)benzoylamino)benzyloxy}aspartate (TFB-TBOA) an untransportable inhibitor that primarily inhibits GLT-1 and GLAST but also substantially targets the neuronal transporter EAAC1 (ref. 25) . If the LTP impairments were due to glutamate transporter upregulation, TFB-TBOA should rescue the LTP defects. Indeed, the application of TBS in the presence of TFB-TBOA induced similar amounts of synaptic potentiation in CA1-cre;Epha4 lx/-and Efna3 -/-mice compared to their respective controls (Fig. 5f,g) . Interestingly, the presence of TFB-TBOA also allowed normal postsynaptic depolarization in CA1-cre;Epha4 lx/-and Efna3 -/-slices during the application of TBS (slope 4/ slope 1: 1.23 ± 0.16 in CA1-cre;Epha4 lx/-, n = 9 slices, 7 mice versus 1.30 ± 0.08 in Epha4 lx/-, n = 13 slices, 7 mice, t-test, P = 0.7; 1.24 ± 0.19 in Efna3 -/-, n = 12 slices, 8 mice versus 1.34 ± 0.12 in Efna3 +/+ , n = 11 slices, 8 mice, t-test, P = 0.7). These results suggest that the impaired LTP observed in CA1-cre;Epha4 lx/-and Efna3 -/-mice is largely due to the reduced levels of glutamate near synapses, caused by increased glutamate transport into astrocytes.
Overexpression of ephrin-A3 in astrocytes
To obtain further support for regulation of glial glutamate transport by ephrin-A3, we generated transgenic lines overexpressing ephrin-A3 (fused to a hemagglutinin epitope tag) in glial cells using the GFAP promoter 26 (Supplementary Fig. 7a ). Two lines (Tg181 and Tg7047) produced viable offspring and were further analyzed. Based on quantitative reverse transcription (qRT)-PCR analysis, Tg181 hippocampi contained 4.5 times the endogenous ephrin-A3 abundance (Supplementary Fig. 7e ). Anti-hemagglutinin immunostaining of P30-P60 brain sections revealed the typical scattered distribution expected for glial cells (Fig. 6a,b and Supplementary a r t I C l e S Fig. 7b,c) . Endogenous EphA4 phosphorylation was higher in hippo campal lysates from Tg181 mice than in those from littermate controls (Fig. 6c) , indicating that the transgenic protein was functional and that EphA4 efficiently interacted with glial ephrin-A3. We confirmed ephrin-A3 overexpression in the fine processes of astrocytes by using a GFAP-GFP indicator line 26 ( Fig. 6d-g ).
To investigate the effects of transgenic ephrin-A3 on endogenous glial glutamate transporter abundance, we co-stained hippocampal sections from Tg181 mice with hemagglutinin and GLAST or GLT1 antibodies (Fig. 6) . We selected areas of high, medium and low hemagglutinin immunoreactivities and compared average pixel intensities in the same areas to those produced by immunostaining for glial transporters. An inverse correlation was seen between hemagglutinin and GLAST/GLT1 expression (Fig. 6k,o) ; similar reductions of glial glutamate transporter abundance were observed in line Tg7047, which expressed lower amounts of transgenic ephrin-A3 than Tg181 (Supplementary Fig. 7) , suggesting that modest overexpression of ephrin-A3 is sufficient to reduce glial glutamate transporter expression. To verify that the transgenic protein was not targeted to a subpopulation of astrocytes that express less of the glutamate transporters, we co-stained hippocampal sections from the GFAP-GFP indicator line with GFP and GLAST or GLT1 antibodies. We found that the expression of glutamate transporters did not correlate with the expression of GFP in astrocytes (Fig. 6p-s and Supplementary  Fig. 7) . These results indicate that ephrin-A3 in astrocytes is sufficient to suppress glial glutamate transporter expression.
Reduction of glial glutamate transporters has previously been shown to increase synaptic glutamate concentrations and to cause epilepsy and neurodegeneration [27] [28] [29] . Excessive glutamate concentrations cause excitotoxicity that is reflected in dendritic beading and spine loss 30 . To assess the degree of dendritic beading in ephrin-A3 transgenic mice, we performed biolistic labeling of neurons with DiI or intercrossed Tg181 with a transgenic line (GFP-M) which expresses GFP in small neuronal subsets 31 . CA1 neurons in P29-P31 hippocampal slices derived from Tg181 mice, but not from wild-type littermates, showed dendritic beading (Fig. 7a-d) with variable penetrance possibly owing to variable expression of the transgene (38.8 ± 3.0% of swelling coverage, n = 16 dendrites, 6 mice, in Tg181; versus 21.7 ± 5.7%, n = 10 dendrites, 6 mice, in littermate controls, t-test, P = 0.003). Neurons from line Tg181 also showed significant spine loss (1.37 ± 0.06 spines µm -1 in Tg181, n = 16 dendrites, 6 mice; versus 1.58 ± 0.07 spines µm -1 in wild-type control mice, n = 10 dendrites, 6 mice; t-test, P = 0.02), probably as an indirect consequence of beading 32 . Dendritic beading can also be induced in hippocampal slice cultures by application of agonists of ionotropic glutamate receptors 30 . In cultured slices derived from line Tg181, neurons did not contain dendritic beads. However, they were more sensitive to glutamate bath application than control slices (Fig. 7e-g ). Deficiency in glial glutamate transporters results in increased sensitivity to pentylenetetrazole (PTZ)-induced seizures 28, 29 . Consistent with these reports, Tg181 mice showed increased seizure severity and more whole-body myocloni after application of PTZ (45 mg per kilogram body weight) than controls (Fig. 7h,i) . These results suggest that overexpression of ephrin-A3 in astrocytes downregulated glutamate transporter levels, which caused glutamate excitotoxicity and exacerbated PTZ-induced seizures.
DISCUSSION
The results presented here show a new mechanism by which astrocytes modulate neuronal plasticity in the CA1 region of the hippocampus. Astrocytes receive a signal from dendritic EphA4 receptors by means of ephrin-A3, which prevents them from upregulating glial glutamate transporter expression to unphysiologically high levels. Dendritic EphA4 and ephrin-A3 in astrocytes thereby control glutamate concentrations near synapses and promote LTP. In the absence of either dendritic EphA4 or ephrin-A3, the abundance of glutamate transporters is increased (see also ref. 19) and glutamate is more efficiently removed during high-frequency stimulation. As a consequence, peri-and extrasynaptic glutamate receptors 33, 34 may not be sufficiently activated, resulting in insufficient depolarization of the postsynapse and partial impairment of LTP. These findings are consistent with previous observations in the cerebellum, where synaptic plasticity is controlled by the neuronal glutamate transporter EAAT4 35, 36 . They also concur with previous observations that glutamate transporter levels are regulated by neuronal activity 7 . Induction of LTP in area CA1 has been shown to increase both neuronal 37 and glial 6 glutamate uptake. It is therefore possible that neuronal activity regulates EphA4-ephrin-A3 signaling to control glial glutamate transport and in this way fine-tune synaptic transmission. 
a r t I C l e S
We cannot exclude the possibility that the observed changes in LTP are exacerbated by morphological changes. Previous studies in the hypothalamus have shown that reduced astrocyte coverage enhanced extracellular glutamate concentrations and activation of metabotropic glutamate receptors 24 . It is also possible that loss of EphA4 and ephrin-A3 changes the motility of astrocytic processes, as previously suggested based on stimulation with Fc fusion proteins 38, 39 . However, we found that pharmacological inhibition of glutamate reuptake rescued the LTP defects, arguing that the observed LTP defects in EphA4 and ephrin-A3 mutant mice were caused by deficiencies in acute signaling rather than by morphological alterations. The fact that LTP defects were only observed after TBS, not tetanus, could be explained by the intrinsic capacity of transporters to clear glutamate. TBS consists of short trains of high-frequency stimulations with interburst intervals of 200 ms, which lead to modest glutamate release and to glutamate concentrations that are sensitive to transporter abundance 40 . We showed that transporter currents are higher in Efna3 -/-than in control mice, also under TBS conditions, suggesting that these modest glutamate elevations are cleared more efficiently than normal and thereby reduce the degree of postsynaptic depolarization during LTP induction. Using a stronger stimulation protocol, such as tetanus, which leads to much higher glutamate release, may overwhelm the capacity of the transporters. In that case, the increase in glutamate transporters in mutant mice may be as ineffective as in control mice at buffering extracellular glutamate. Alternatively, tetanus stimulation may influence transporter currents by mechanisms independent of Eph-ephrin signaling.
EphA4 is expressed both pre-and postsynaptically 20 , but here we have discovered that only the postsynaptic fraction of EphA4 plays a role in LTP. Therefore, the previously suggested model of axonal EphA4 activating ephrin-B reverse signaling in spines is probably incorrect 12 . To be able to activate ephrin-Bs, EphA4 would have to interact with ephrin-Bs in cis, which we consider unlikely. Instead, the results in this study (see also ref. 19) suggest that EphA4 interacts with astrocytic ephrin-A3. The requirement for postsynaptic, but not presynaptic, EphA4 could be explained by the fact that glial coverage at hippocampal synapses is asymmetrically distributed, with threefold more glial contact with spines compared to presynaptic boutons 41 . The role of EphA4 in LTP is independent of forward signaling 12 and therefore distinct from its role in spine morphogenesis 11 . It is likely that the EphA4 ectodomain activates ephrin-A3 reverse signaling in astrocytes; however, the mechanism that regulates glial glutamate transporter levels downstream of ephrin-A3 is currently unknown. As ephrin-A3 mRNA is also detectable in pyramidal neurons (data not shown), we cannot formally rule out a function of ephrin-A3 in hippocampal neurons.
What are the physiological and pathophysiological implications of our observations? Hippocampal LTP is a critical component of the cellular mechanisms underlying certain aspects of learning and memory 42 . Efna3 -/-mice were shown to have impairments in certain behavioral tests requiring the hippocampus 19 , suggesting that the regulation of glial glutamate transport and synaptic plasticity may be critical for certain forms of hippocampal learning. Moreover, the phenotypes described in the ephrin-A3 transgenic lines suggest that mechanisms promoting ephrin-A3 reverse signaling may contribute to lowering glutamate transporter expression, which results in glutamate excitotoxicity [27] [28] [29] . Dysfunction of glial glutamate transporters is implicated in the pathology of various neurological and neurodegenerative diseases, such as epilepsy and amyotrophic lateral sclerosis (ALS) 3, 22 . Notably, the human VAPB protein, a diffusible ligand for Eph receptors and potential antagonist for ephrins, is associated with familial ALS 43 . Mutations of VAPB might enhance EphA4-ephrin-A3 signaling, thereby causing the downregulation of glial glutamate transporters observed in ALS.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
western blot analysis and immunoprecipitation. Tissues were homogenized in ice-cold buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton X-100) supplemented with protease inhibitor cocktail tablets and phosphatase inhibitor cocktail tablets (Roche). The lysates were separated by SDS-PAGE and probed by immunoblotting with the following primary antibodies: EphA4 mouse monoclonal (anti-Sek, Becton Dickinson Biosciences), 1:1,000; EphA4 rabbit polyclonal serum 1383 (raised against an intracellular peptide 46 ), 1:1,000; EphA4 globular domain rabbit polyclonal serum 1078 (ref. 46), 1:1,000; GFAP rabbit polyclonal (DAKO), 1:2,000; GFAP mouse monoclonal (Sigma), 1:1,000; GLAST guinea pig polyclonal (Chemicon), 1:5,000; GLT1 guinea pig polyclonal (Chemicon), 1:2,000; EAAC1 mouse monoclonal (Chemicon), 1:500; hemagglutinin rat monoclonal clone 3F10 (Sigma), 1:2,000; phosphotyrosine (pTyr, hybridoma clone 4G10), 1:10,000; tubulin mouse monoclonal clone DM 1A (Sigma), 1:50,000. Horseradish peroxidase (HRP)-conjugated secondary antibodies (Amersham Biosciences), 1:5,000. Detection was performed with luminol (Santa Cruz). For immunoprecipitations, hippocampal lysates were incubated with Protein A-Sepharose beads (Amersham) preconjugated with EphA4 serum 1383. Western blots were quantified using ImageJ software. Optical density values were normalized to tubulin signal. Glutamate transporter proteins tend to form homomultimers 47 . For GLAST a more prominent band of 120 kDa was quantified, probably corresponding to the dimeric form. For GLT1 a band of 70 kDa was quantified, corresponding to the monomeric form.
Immunofluorescence and immunohistochemistry. Mice were perfused with 4% paraformaldehyde in phosphate-buffered saline (PBS). Brains were postfixed overnight and further processed or cryoprotected in 30% sucrose before freezing. For immunofluorescence, vibratome free-floating sections (50 µm thick) were permeabilized with 0.5% TritonX-100 in PBS, blocked in 0.1% TritonX-100, 5% BSA and 5% donkey serum in PBS for 1 h at 24-26 °C and incubated with primary antibodies overnight at 4 °C in blocking solution: GLAST rabbit polyclonal (Frontier Science), 1:5,000; GLT1 guinea pig polyclonal (Chemicon), 1:5,000; hemagglutinin rat monoclonal clone 3F10 (Sigma), 1:1,000; GFAP rabbit polyclonal (DAKO), 1:1,000; GFP rabbit polyclonal (RDI), 1:1,000; GFP mouse monoclonal antibody (Molecular Probes), 1:2,000. The sections were washed three times in PBS with 0.1% Triton X-100 for 30 min and incubated for 1 h at 24-26 °C with donkey Cy2, Cy3 and Cy5-conjugated secondary antibodies (Jackson ImmunoResearch), diluted 1:800 in blocking solution, mounted using aqueous mounting medium with antifading reagent (Biømeda). The Vectastain ABC kit (Vector Laboratories) was used for immunohistochemistry, the staining procedure was adapted according to provider's instructions.
Assessment of dendrite morphology. To visualize hippocampal neurons in vivo, P29-P31 mice carrying the Thy-GFP transgene were perfused, hippocampi were dissected, and 200-µm-thick, coronal vibratome sections were collected. Alternatively, 400-µm hippocampal slices were prepared using a custom-made tissue slicer and labeled with DiI using a biolistic method. Fluorescence images from apical dendrites were acquired in the stratum radiatum of the CA1 region with a TCS SP2 confocal microscope (Leica). Quantification of dendritic spines and swellings were done on the thinnest dendrites (0.3-0.5 µm diameter) in single confocal z-sections. Swellings were defined as enlargements of the mean dendritic stalk width. All quantitative measurements were performed using MetaMorph software (Molecular Devices). For analysis of spine morphology in cultured slices, two stacks of pictures per slice in the stratum radiatum of the CA1 region were acquired. To automatically delineate the dendrites, the stack projections were quantified with an automatic counting-grid macro implemented in the MetaMorph software (dendrite complexity index) 48 . All image analyses were done by an investigator blind to the genotype. organotypic hippocampal slice cultures. Hippocampal slices (300 µm thick) were prepared from P6 progeny of Tg181 mice crossed to GFP-M mice and maintained using the Muller technique 49 . Slices were kept in culture for 5 d before the experiments. glutamate exposure. Slice cultures were exposed to glutamate at concentrations of 0-120 µM glutamate for 1 h at 35 °C and then immediately fixed with 2% paraformaldehyde, 15% glucose. Glutamate was dissolved in water and applied to the culture medium.
PtZ treatment. Mice were injected intraperitoneally with 45 mg per kilogram body weight PTZ (Sigma), diluted in saline. After injection, mice were carefully monitored and videotaped.
Quantitative Rt-PcR analysis. Total RNA was isolated from hippocampi of P60 mice using Rneasy Mini Kit (Qiagen) according to the manufacturer's instructions. Total RNA (100 ng) was reverse transcribed and amplified using the One-Step RT-PCR system LightCycler RNA Master SYBR Green I (Roche Applied Science) in triplicates, using the LightCycler (Roche Applied Science). QuantiTect Primer Assays (Qiagen) were used for Slc1a3 (Mm_Slc1a3_1_SG), Slc1a2 (Mm_Slca2_1_SG), GFAP (Mm_Gfap_1_SG) and Gapdh (Mm_Gapd_ 2_SG). For Efna3, primers were designed common to the mouse and human sequence RT-A3exon2/3.F (5′-GTTCTCCGAGAAGTTCCAGC-3′) and RT-A3exon2/3.R (5′-CAGTGCAGGTTGTGAGTGGG-3′). The threshold cycle C t was determined manually. Taking into account that primers used had the same amplification efficiency, experiments were analyzed by relative quantification using the 2 -∆∆ Ct method 50 .
Statistical analysis. Statistical significance was determined using two-tailed Student's t-tests in Microsoft Excel, two-way analysis of variance (ANOVA) with repetitions using the software Statistics (Blackwell Scientific Publications), analysis of covariance (ANCOVA) from the VasserStats statistical computations website (http://faculty.vassar.edu/lowry/VassarStats.html) and two-sample KolmogorovSmirnov tests using the Statistics to Use website (http://www.physics.csbsju. edu/stats/KS-test.html; T.W. Kirkman, 1996) . The Mann-Whitney U-test was performed using SPSS software (release 11.0; SPSS Inc.). All values in the text and in the figure legends indicate mean ± s.e.m. All error bars in the graphs represent s.e.m.
